Simulations Plus (NASDAQ:SLP) Share Price Crosses Above 200-Day Moving Average – Time to Sell?

Shares of Simulations Plus, Inc. (NASDAQ:SLP) crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $15.44 and traded as high as $18.25. Simulations Plus shares last traded at $18.21, with a volume of 504,876 shares traded.

Analyst Ratings Changes

Several equities research analysts recently weighed in on the company. Wall Street Zen lowered Simulations Plus from a “buy” rating to a “hold” rating in a research report on Saturday, June 13th. Weiss Ratings upgraded shares of Simulations Plus from a “sell (d)” rating to a “sell (d+)” rating in a report on Friday, July 10th. TD Cowen decreased their price target on shares of Simulations Plus from $19.00 to $16.00 and set a “hold” rating for the company in a research note on Friday, April 10th. Craig Hallum cut shares of Simulations Plus from a “buy” rating to a “hold” rating and set a $18.50 price target for the company. in a research report on Thursday, June 18th. Finally, William Blair downgraded shares of Simulations Plus from an “outperform” rating to a “market perform” rating in a research note on Wednesday, June 17th. Seven research analysts have rated the stock with a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Reduce” and a consensus target price of $17.25.

Simulations Plus Trading Down 0.1%

The stock’s 50 day moving average is $16.88 and its 200-day moving average is $15.44. The company has a market cap of $368.39 million, a P/E ratio of 45.52 and a beta of 1.30.

Simulations Plus (NASDAQ:SLP) last issued its earnings results on Thursday, July 9th. The technology company reported $0.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.23 by $0.07. Simulations Plus had a net margin of 9.88% and a return on equity of 13.50%. The business had revenue of $21.89 million during the quarter, compared to analysts’ expectations of $20.90 million. As a group, sell-side analysts forecast that Simulations Plus, Inc. will post 0.8 EPS for the current year.

Insider Buying and Selling

In other Simulations Plus news, Director Walter S. Woltosz sold 4,177 shares of Simulations Plus stock in a transaction on Wednesday, July 1st. The stock was sold at an average price of $18.44, for a total value of $77,023.88. Following the completion of the sale, the director owned 3,202,131 shares of the company’s stock, valued at approximately $59,047,295.64. This trade represents a 0.13% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 19.10% of the company’s stock.

Institutional Investors Weigh In On Simulations Plus

Several large investors have recently bought and sold shares of SLP. Tudor Investment Corp ET AL bought a new position in Simulations Plus during the 3rd quarter valued at about $1,810,000. Nicholas Company Inc. lifted its position in Simulations Plus by 42.9% during the fourth quarter. Nicholas Company Inc. now owns 262,712 shares of the technology company’s stock valued at $4,789,000 after purchasing an additional 78,854 shares during the period. JPMorgan Chase & Co. lifted its position in Simulations Plus by 154.7% during the third quarter. JPMorgan Chase & Co. now owns 167,646 shares of the technology company’s stock valued at $2,526,000 after purchasing an additional 101,822 shares during the period. GSA Capital Partners LLP boosted its holdings in Simulations Plus by 167.9% in the fourth quarter. GSA Capital Partners LLP now owns 62,322 shares of the technology company’s stock worth $1,136,000 after purchasing an additional 39,059 shares during the last quarter. Finally, Nano Cap New Millennium Growth Fund L P bought a new stake in Simulations Plus in the 4th quarter worth approximately $1,768,000. 78.08% of the stock is currently owned by institutional investors.

Simulations Plus Company Profile

Simulations Plus, Inc (NASDAQ: SLP) specializes in advanced modeling and simulation software tailored to the pharmaceutical, biotechnology and chemical industries. The company’s flagship products include ADMET Predictor, a quantitative structure-activity relationship (QSAR) tool for predicting absorption, distribution, metabolism, excretion and toxicity properties, and GastroPlus, a physiologically based pharmacokinetic (PBPK) modeling platform for simulating drug absorption and pharmacokinetics.